Musculoskeletal Cancers Remote Monitoring and Care (NCT07129226) | Clinical Trial Compass
RecruitingNot Applicable
Musculoskeletal Cancers Remote Monitoring and Care
United States60 participantsStarted 2026-02-11
Plain-language summary
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* primary sarcoma or metastatic bone disease of the lower extremities or pelvis.
* undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention.
* recent history of home ambulation.
Exclusion Criteria:
* under 18 years of age at the time of study enrolment
* inability to comprehend consent form and give informed consent
* no access to a smartphone (iOS or Android) to interface with watch application
* tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function
* amputation or other disease of the arm or skin that prevents wear of a smart-watch device
* inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Adherence Rate post surgery in patients with sarcoma of the lower extremity or pelvis
Timeframe: 3 months
2
e-QOL post-surgery in patients with sarcoma of the lower extremity or pelvis
Timeframe: 3 months
3
Adherence Rate post surgery in patients with metastatic bone disease of the lower extremity or pelvis
Timeframe: 3 months
4
e-QOL post-surgery in patients with metastatic bone disease of the lower extremity or pelvis
Timeframe: 3 months
5
Adherence Rate post-radiation in patients with metastatic bone disease of the lower extremity or pelvis
Timeframe: 3 months
6
e-QOL post-radiation in patients with metastatic bone disease of the lower extremity or pelvis